Urine tests can detect cervical cancer viruses, make screening easy
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
HQ Team May 7, 2024: A target of one billion additional people enjoying better health and well-being is likely to be met by.
HQ Team April 30, 2024: The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond.
HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.
By K. Leelamoni December 12, 2023: The Human Papilloma Virus (HPV) is the name of a group of viruses of 200 known viruses..
Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health.
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Merck and Bio Farma of Indonesia sign deal to produce HPV vaccine for cervical cancer